載入...
The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma
Insights into the biology of advanced renal cell carcinoma (aRCC) and the development of agents targeting the vascular endothelial growth factor (VEGF) pathway have positively impacted the outcomes for patients with aRCC. With the recent approval of the dual immune checkpoint inhibitors (ICIs), nivo...
Na minha lista:
Main Authors: | , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Frontiers Media S.A.
2019-01-01
|
叢編: | Frontiers in Immunology |
主題: | |
在線閱讀: | https://www.frontiersin.org/article/10.3389/fimmu.2018.03120/full |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|